Clinical Trial Update: Anti-Retrovirals for Kaposi's Sarcoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating antiretroviral therapy for Kaposi's sarcoma in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Kaposi Sarcoma

Drugs mentioned

• Antiretroviral therapy

Snippet

Sponsor: University of California, San Francisco | Conditions: Kaposi's Sarcoma, HIV Infections | Phase 4 | Status: COMPLETED